People with multiple sclerosis (MS) who have vitamin D levels above 30 ng/ml have preserved myelin compared to people with MS who have levels below 30 ng/ml.
Why this matters
Vitamin D deficiency is associated with increased risk of relapsing remitting MS (RRMS); however, there are limited data about the association between vitamin D and primary progressive MS (PPMS) and secondary progressive MS (SPMS).
Additionally, there is an increase in lesion formation in people with MS who have a vitamin D deficiency; however, there have been mixed clinical outcomes from vitamin D supplementation.
Want to read more?
Log in or sign up to access all Neurodiem content.
Already have an account? Log In
International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.
No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.